DUBLIN, Oct. 13, 2020 /PRNewswire/ -- The "Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This Rheumatoid Arthritis (RA) - ...
DUBLIN–(BUSINESS WIRE)–Feb 8, 2021– The "US Rheumatoid Arthritis Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. The latest research US Rheumatoid ...
Rheumatoid Arthritis companies are Taisho Pharmaceuticals, R-Pharm, GlaxoSmithKline, Aclaris Therapeutics, Pfizer, Abivax, Bristol Myers Squibb, Oscotec/Genosco ...
More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.
Over 10 years, nearly 13% of patients with seronegative rheumatoid arthritis receive a new diagnosis, most often ...
Historically, psoriatic arthritis was presumed to be simply a variation of rheumatoid arthritis in patients who also happened to have psoriasis. Verna Wright, a professor in Leeds, UK, first proposed ...
The "US Psoriatic Arthritis Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. US Psoriatic Arthritis Market and Competitive Landscape Highlights – ...
Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results